• Genmab average price to free cash flow ratio for 2023 was 26.9, a 62.65% decline from 2022.
• Genmab average price to free cash flow ratio for 2022 was 72.02, a 21% decline from 2021.
• Genmab average price to free cash flow ratio for 2021 was 91.16, a 183.9% decline from 2020.

Price to free cash flow ratio can be defined as